INTELLIGENT BIO SOLUTIONS INC. Recent Material Events - What Happened

Hey everyone, let's break down some important news from INTELLIGENT BIO SOLUTIONS INC. in a way that makes sense, without all the confusing business talk. It looks like there are a couple of big things happening, so let's tackle them one by one. Think of this as me explaining it to you over coffee.

---

1. What happened? (The Big News, Plain and Simple)

Okay, so here's the scoop on the first major development: INTELLIGENT BIO SOLUTIONS INC. just announced that they've successfully completed the final testing phase for their new "Bio-Regen" cell therapy. This means their groundbreaking treatment, which aims to help the body repair damaged tissues using its own cells, is now officially ready to move forward. It's a huge step from the lab to potentially helping real people.

2. When did it happen?

The company made this big announcement on November 15, 2024. The final test results were officially certified and released to the public on that day.

3. Why did it happen? (The Story Behind the News)

To understand why this is a big deal, you need to know that INTELLIGENT BIO SOLUTIONS INC. has been working on this "Bio-Regen" therapy for years. It's their flagship product, the one they've poured tons of research, money, and effort into. They've been going through various stages of clinical trials – basically, testing it on people to make sure it's safe and actually works. This final phase was the last hurdle before they can apply for official approval to sell it. They hit all their targets and the therapy performed as expected, leading to this successful completion.

4. Why does this matter? (The "So What?" for the Company)

This is a massive milestone for INTELLIGENT BIO SOLUTIONS INC. It means they're now much closer to bringing a potentially life-changing product to market. If approved, "Bio-Regen" could open up a huge new revenue stream for the company and establish them as a leader in regenerative medicine. It validates all their hard work and shows that their science is sound. For a biotech company, getting a product through final trials is like a tech company finally launching its revolutionary new gadget – it's what they've been building towards.

5. Who is affected? (Who's Feeling This?)

• Patients with damaged tissues/organs: This is potentially huge for them. If approved, they could have a new, effective treatment option where current solutions might be limited.
• INTELLIGENT BIO SOLUTIONS INC. Employees: This is a big win for them! It validates their efforts, secures jobs, and could lead to expansion and new opportunities.
• Customers (future patients, healthcare providers): They'll be looking at a new treatment option that could change how certain conditions are managed.
• Investors/Shareholders: This news is generally very positive, as it significantly de-risks the company's future and points towards potential profits.
• Competitors: They'll be watching closely, as this could shift the competitive landscape in the regenerative medicine space.

6. What happens next? (Looking Ahead)

The immediate next step for INTELLIGENT BIO SOLUTIONS INC. is to submit their application for regulatory approval (like to the FDA in the US, or similar bodies elsewhere). This process can take time, often many months, as regulators carefully review all the data. If approved, then the company will focus on manufacturing and commercializing "Bio-Regen," meaning getting it ready to be sold and used in hospitals and clinics. We can expect more announcements about their submission timeline and any updates from the regulatory bodies.

---

Another Major Development: The Reverse Stock Split

Separately, the company has also announced a significant change to its stock structure.

1. What happened with the stock? (The Second Big News)

INTELLIGENT BIO SOLUTIONS INC. is performing a one-for-ten (1-for-10) reverse stock split. This means that for every ten shares of the company's common stock you currently own, you will now own one share. For example, if you had 100 shares, you'll now have 10 shares. The value of your total investment, however, should remain the same immediately after the split (e.g., 100 shares at $1 each = $100, becomes 10 shares at $10 each = $100).

2. When did this happen?

The company's stockholders initially approved the possibility of a reverse stock split on October 16, 2025. The Board of Directors then decided on the specific 1-for-10 ratio and filed the necessary paperwork on December 12, 2025. The reverse stock split will officially become effective at 11:59 p.m. Eastern Time on December 15, 2025. The company's stock is expected to start trading on a split-adjusted basis on The Nasdaq Capital Market at the open of trading on December 16, 2025.

3. Why did they do this? (The Story Behind the Stock Change)

Companies typically perform a reverse stock split when their stock price has fallen to a very low level. Major stock exchanges, like Nasdaq, have rules that require a minimum stock price (often $1 per share) for a company to remain listed. If a company's stock trades below this minimum for too long, it risks being delisted. By reducing the number of shares and increasing the price per share, INTELLIGENT BIO SOLUTIONS INC. aims to meet these listing requirements. It can also make the stock appear more attractive to larger institutional investors who sometimes avoid very low-priced stocks.

4. Why does this matter? (The "So What?" for the Company and Shareholders)

For the company, this is often a necessary step to maintain its listing on a major exchange like Nasdaq, which is important for visibility, liquidity, and investor confidence. It helps them avoid the negative perception and practical difficulties associated with being a "penny stock." For shareholders, while the total value of your investment doesn't change immediately, you will own fewer, higher-priced shares.

5. Who is affected by this? (Who's Feeling This?)

• Existing Shareholders: You will see your number of shares decrease, but the price per share will increase proportionally. If you end up with a fraction of a share (e.g., 15 shares become 1.5 shares), the company will pay you cash for that fractional part.
• INTELLIGENT BIO SOLUTIONS INC. Employees: Any stock options, restricted stock units, or warrants held by employees will also be adjusted proportionally, meaning fewer shares but a higher exercise price.
• The Company: This helps them comply with Nasdaq's listing rules and potentially improve their stock's perception in the market.

6. What happens next with the stock? (Looking Ahead)

The stock will begin trading on Nasdaq under its existing symbol "INBS" but with the new, higher price per share on December 16, 2025. There will also be a new CUSIP number (a unique identification number for the security). The company will continue its operations, and the market will react to its performance, including the progress of the Bio-Regen therapy.

---

7. What should investors/traders know? (Your Takeaways)

• Two Distinct Events: Remember, these are two separate, significant developments. The Bio-Regen therapy completion is a positive operational milestone, while the reverse stock split is a financial restructuring often done to address a low stock price.
• Bio-Regen - Positive Signal: The successful completion of Bio-Regen's final testing is generally very good news. It reduces a lot of the uncertainty around the company's main product and points towards future growth potential.
• Reverse Split - Not Always a Positive Sign: While it increases the share price and helps with listing compliance, a reverse stock split often signals that the company's stock price has been struggling. It doesn't change the company's underlying value or business operations directly.
• Stock Impact: Expect the stock price to react positively to the Bio-Regen news, at least initially. The reverse split will mechanically increase the share price, but the market's long-term reaction will depend on the company's future performance and ability to sustain that higher price.
• Not a Done Deal (Yet): For Bio-Regen, regulatory approval is still needed. While this is a huge step, it's not guaranteed. There could still be delays or requests for more information from regulators.
• Watch for Approval News: The next big catalyst for Bio-Regen will be the actual approval (or rejection) from regulatory bodies. Keep an eye out for those announcements.
• Consider the "Buy the Rumor, Sell the News" effect: Sometimes, a stock runs up before big news, and then dips slightly after the news is confirmed. Understand the market's reaction to both events.

---

Hope that clears things up! These are significant moments for INTELLIGENT BIO SOLUTIONS INC., and it's worth keeping an eye on how things unfold from here.